Analysis on the Clinical Features of 507 HDV-Infected Patients

Cell Biochemistry and Biophysics

Volumn 70, Issue 3, 2014, Pages 1829-1832

  Gu, Xiao Hong ^a   Chen, Zhuo ^a   Dai, Ruo Yi ^a   Zhang, Min Li ^a   Tang, Hou Mei ^a   Chen, Lan Bo ^a   Dong, Bo ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Clinical feature; Hepatitis D; Pathogenesis

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; HEPATITIS ANTIBODY; HEPATITIS B ANTIBODY; HEPATITIS B(E) ANTIGEN; HEPATITIS DELTA ANTIGEN;

ADULT; BLOOD; COHORT ANALYSIS; COMPLICATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMAN; INCIDENCE; LIVER CIRRHOSIS; MALE; METABOLISM; MIDDLE AGED; PROTHROMBIN TIME; SEVERITY OF ILLNESS INDEX; VIROLOGY;

ADULT; ALANINE TRANSAMINASE; BILIRUBIN; COHORT STUDIES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS D; HEPATITIS DELTA ANTIGENS; HEPATITIS DELTA VIRUS; HUMANS; INCIDENCE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROTHROMBIN TIME; SEVERITY OF ILLNESS INDEX;

EID: 84936747490     PISSN: 10859195     EISSN: 15590283     Source Type: Journal    
DOI: 10.1007/s12013-014-0137-8     Document Type: Article

References (11)

1. Hughes, S. A., Wedemeyer, H., & Harrison, P. M. (2011). Hepatitis delta virus. Lancet,378(9785), 73–85.
2. Rizzetto, M. (1983). The delta agent. Hepatology,3(5), 729–737.
3. Rizzetto, M. (1989). Hepatitis delta virus (HDV) infection and disease. RIC Clinical Laboratory,19(1), 11–26.
4. Grabowski, J., & Wedemeyer, H. (2010). Hepatitis delta: Immunopathogenesis and clinical challenges. Digestive Diseases,28(1), 133–138.
5. Pascarella, S., & Negro, F. (2011). Hepatitis D virus: An update. Liver International,31(1), 7–21.
6. Romeo, R. (2010). Role of the hepatitis delta virus on the pathogenesis of hepatic cirrhosis and hepatocellular carcinoma. Recent Advances in Medicine,101(2), 52–56.
7. Tang, J. R., Cova, L., Lamelin, J. P., et al. (1994). Clinical relevance of the detection of hepatitis delta virus RNA in serum by RNA hybridization and polymerase chain reaction. Journal of Hepatology,21(6), 953–960.
8. Gish, R. G., Yi, D. H., Kane, S., et al. (2013). Coinfection with hepatitis B and D: Epidemiology, prevalence and disease in patients in Northern California. Journal of Gastroenterology and Hepatology. doi:10.1111/jgh.12217.
9. Lu, S. N., Chen, T. M., Lee, C. M., et al. (2003). Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan. Journal of Medical Virology,70(1), 74–80.
10. Tappero, G., Natoli, G., Anfossi, G., et al. (1994). Expression of the c2myc protoncogene production in cells infected with the hepatitis delta virus. Hepatology,19(5), 1101–1114.
11. Oliveri, F., Brunetto, M. R., & Baldi, M. (1991). Hepatitis delta virus (HDV) infection and hepatocellular carcinoma (HCC). Progress in Clinical and Biological Research,364, 217–222.